SCHEMBL16976598

SCHEMBL16976598

O=Cc1ccc(Cl)c(C(F)(F)P)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.53
▸ VCAM1 P19320 1/20 0.43
▸ NPFFR1 Q9GZQ6 2/20 0.40
▸ NPFFR2 Q9Y5X5 2/20 0.40
▸ HSD17B10 Q99714 1/20 0.39
▸ ALDH1A3 P47895 3/20 0.39
▸ KIF11 P52732 1/20 0.38
▸ KDR P35968 2/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ ALDH3A1 P30838 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ PTGS2 P35354 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ CYP2A6 P11509 1/20 0.34
▸ TTR P02766 1/20 0.34
▸ CYP1A2 P05177 1/20 0.33
▸ TSHR P16473 1/20 0.32
▸ NR3C1 P04150 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL40676 0.85 ALDH1A1 (0.57) ALDH1A1VCAM1NPFFR1NPFFR2HSD17B10
SCHEMBL16475651 0.81 ALDH1A1 (0.53) ALDH1A1VCAM1NPFFR1NPFFR2HSD17B10
SCHEMBL16381881 0.81 ALDH1A1 (0.53) ALDH1A1VCAM1NPFFR1NPFFR2HSD17B10
SCHEMBL11132179 0.79 ALDH1A1 (0.50) ALDH1A1VCAM1NPFFR1NPFFR2HSD17B10
Ethane SCHEMBL2153516 0.76 ALDH1A1 (0.55) ALDH1A1VCAM1NPFFR1NPFFR2HSD17B10
SCHEMBL18002824 0.75 ALDH1A1 (0.46) ALDH1A1VCAM1NPFFR1NPFFR2KIF11
SCHEMBL29417704 0.73 ALDH1A1 (0.57) ALDH1A1VCAM1NPFFR1NPFFR2HSD17B10
SCHEMBL472520 0.73 ALDH1A1 (0.57) ALDH1A1VCAM1NPFFR1NPFFR2HSD17B10
SCHEMBL11132181 0.73 ALDH1A1 (0.52) ALDH1A1VCAM1HSD17B10ALDH1A3KIF11
SCHEMBL17115582 0.71 KIF11 (0.63) ALDH1A1NPFFR1NPFFR2KIF11KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2902030-B1 Thienotriazolodiazepine compounds for treating neoplasia DANA FARBER CANCER INST INC (US) 2016-09-14 — — EP disclosed
EP-2902030-A1 Thienotriazolodiazepine compounds for treating neoplasia Dana-Farber Cancer Institute, Inc. (US) 2015-08-05 — — EP disclosed
Send feedback